investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining the impact of clonal evolution on chronic lymphocytic leukemia
Catherine Ju-Ying Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Catherine Ju-Ying Wu
Dana-Farber Cancer Institute
Boston, United States
Related projects
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Katerina V Gurova
Modulation of cancer specific transcriptional factors with small molecules
Leukaemia
James K Chen
Chemical genetic dissection of Hipk4-dependent Hedgehog pathway activation
Leukaemia
Bruno Calabretta
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
Leukaemia
Pathology
Hematology and hematologic malignancies
Samuel Strober
Blood Stem Cell Transplantation as Immunotherapy
Leukaemia
Robert G Roeder
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
Leukaemia
Xuefang Cao
Targeting Granzyme B to Separate GVH from GVL Responses
Leukaemia
Scott A Armstrong
Targeting to Epigenetic Modications in ALL
Leukaemia
Tait D Shanafelt
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies